Archive
See details of previously published customer updates from our Health products team.
Showing 21 - 40 of 51 results
ANSTO joins international counterparts in peaceful nuclear monitoring
The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.
Pioneering collaboration advances nuclear medicine
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
ANSTO to undertake routine shipment of spent fuel in 2025
The women of nuclear stewardship science are experts in the safe use of radioactivity
ANSTO reports
Report to the independent nuclear regulator, ARPANSA, and the IAEA
Superheroes and super science holiday activities for the kids
Accessing ANSTO’s Service Portal
ANSTO offers a broad range of programs and services to various industries and customers. Many of these services, including the Australian Nuclear Medicine Traceability program, are supported by online customer portals.
Visiting Australia
Visiting Australia - ANSTO-HZB Neutron Training Course 2024
Imaging technology has the ability to capture and display gamma radiation
A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.
Update on building 23 at ANSTO
The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.
New information on the human health impacts of radiation
OPAL multi-purpose reactor
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Statement of Intent
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
Australia’s Nuclear Age Celebrates 70 Years
Gamma radiation imaging technology
A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.
Australia is home to one of the world’s best nuclear reactors
Over the past 70 years ANSTO has been building Australia’s nuclear expertise and despite being small in scale, today we are complex and sophisticated nuclear nation.
End of an era for Australia’s first nuclear reactor
Funding backs ANSTO‑led program to develop new treatment for deadly brain cancers
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program